An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy
Clinical trial NCT01281839 · COMPLETED
Trial details
- NCT number
- NCT01281839
- Sponsor
- Janssen R&D Ireland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-02-01
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.